KRAS and non-small cell lung carcinoma: In this study, cancer cell-restricted genetic ablation of mDR in autochthonous KRAS-driven models of non-small cell lung cancer (NSCLC) and PDAC was shown to reduce tumor growth, blunt metastasis, and prolong survival by inhibiting cancer cell-autonomous migration, proliferation, and invasion.